- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03319589
Pilot Study on a Locally Prepared Food Supplement to Support Growth and Brain Health
Study Overview
Detailed Description
Up to 20 children aged 24-30 months and 20 school children aged 6-6.5 years living in each of 2 villages in the Oio region of Guinea-Bissau (total study population up to 80, with no minimum recruitment number) will be recruited for this study, with ages documented by the official birth record, which all families possess. Villages will be a convenience sample chosen from villages within the network of our local research partner International Partnership for Human Development. Each village in this region has one school and one community health center per village, which will be involved in supplement distribution and some outcome assessments. The villages will be broadly comparable in terms of size, affluence, rates of malnutrition, the presence or absence of a school meal program, and tribal affiliation and religion.
One village will be randomly assigned to receive the locally-prepared biscuit and a daily multivitamin and the other will be randomly assigned to be an assessment-only control site. Because this is a pilot study designed to develop methodology for a future powered trial, and the logistics of local supplement preparation need to be developed in advance of the study, the randomization will occur prior to baseline testing to allow for development of infrastructure for supplement preparation. However the villagers will not be informed of the randomization until after baseline testing is complete.
Following baseline measurements of anthropometry, grip strength, cognition, non-invasive measurements of hemoglobin, and skin carotenoids, participants will receive their intervention for 12 weeks and the same measurements taken at baseline will be repeated during the last study week. Since access for the final assessment to villages may be hampered by the rainy season we also request permission to terminate the trial between 9-12 weeks of supplement consumption depending on weather conditions. Please note that cell phone access to villages is not influenced by local weather, thus communication regarding safety issues with community health workers will remain possible throughout the entire trial.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Non-malnourished children within the 2 villages chosen for study
- Within the specified age range: 24-36 months for young children and 6-7 years for older children, who will also be enrolled in their local school. In the event that researchers cannot enroll at least 15 participants in each age range in each village, will extend the age range up to 35.99 months for young children and up to 6.99 years for older children.
- The family plans to remain in the village for the duration of the study;
- The child does not have any known food allergies as reported by the mother or guardian.
Exclusion Criteria:
- If any child is identified as malnourished at baseline, defined as a mid-upper arm circumference in the red zone of the paper tape or a weight-for-age or height-for-age z-score of less than or equal to -3.0, the child will be excluded from the study due to malnutrition, and the parents will be advised to take the child to the nearest malnutrition clinic
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Supplement Arm
School children (age 6 to 6.5) will receive their supplement 5 days a week in the morning before school starts.
They will either receive the supplement at school or at the community health center depending on the preference of the villagers after recruitment.
Young children (age 24 to 30 months) will receive the supplement 5 days a week in the morning at the community health center, distributed by community health workers.
|
locally prepared biscuit with low sugar content (less than 10% weight) designed to facilitate growth and cognitive development
|
No Intervention: Control Arm
Children in the active intervention village will be compared with assessment-only controls in a separate village having comparable demographic characteristics
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in executive cognitive function
Time Frame: Baseline and end line (12 weeks difference)
|
Two measures of executive function, working memory and task-switching abilities, will be administered through play-based games by local research team members.
"Spin the Pots" and "Reverse Categorization" tasks, modeled after Carlson et al., have been age modified and culturally adopted.
|
Baseline and end line (12 weeks difference)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Supplementation Attendance
Time Frame: Through study completion (12 weeks)
|
community health workers will record attendance of children to consume the supplement.
|
Through study completion (12 weeks)
|
Sicknesses
Time Frame: Through study completion (12 weeks)
|
Community health workers will record sickness (malaria, stomach issues, fever) if children to consume the supplement are unwell.
|
Through study completion (12 weeks)
|
Change in hand grip strength
Time Frame: Baseline and end line (12 weeks difference)
|
. In the children aged 6-6.5 years, grip strength in both hands will be measured in duplicate using a dynamometer suitable for pediatric populations
|
Baseline and end line (12 weeks difference)
|
Change in Hemoglobin
Time Frame: Baseline and end line (12 weeks difference)
|
Hemoglobin will be measured non-invasively using a standard technique that uses light of different wavelengths directed at the finger
|
Baseline and end line (12 weeks difference)
|
Change in skin carotenoids
Time Frame: Baseline and end line (12 weeks difference)
|
a non-invasive optical measure of carotenoids in tissue, measured by shining light in the palm of the hand
|
Baseline and end line (12 weeks difference)
|
Change in immune function
Time Frame: Baseline and end line (12 weeks difference)
|
In this study we will measure delayed-type hypersensitivity (DTH) response using a standard Mantoux test composed of 3 antigens and a negative control via 4 intradermal skin injections that will be performed at baseline and the end of the study
|
Baseline and end line (12 weeks difference)
|
Food Product Acceptability
Time Frame: Baseline
|
Mothers (for the young children) and school children will be asked on a 4-point scale of '1=not at all' '2=a little', '3=moderately' and '4=very much' how much they enjoy eating the two types biscuits and the multivitamin.
Preference for one biscuit over another will be determined by a higher total summed up score.
The biscuit with a greater score will be used during the study.
|
Baseline
|
Mother's Height Change
Time Frame: Baseline and end line (12 weeks difference)
|
Height of the mothers measured in cm.
|
Baseline and end line (12 weeks difference)
|
Mother's Weight Change
Time Frame: Baseline and end line (12 weeks difference)
|
Weight of the mothers measured in kg.
|
Baseline and end line (12 weeks difference)
|
Mother's MUAC change
Time Frame: Baseline and end line (12 weeks difference)
|
The weight, height and MUAC of the mothers will also be measured, and family demographic data (family size, number of wives and children and ages) will be collected by questioning the mother.
|
Baseline and end line (12 weeks difference)
|
Family Demographics Change
Time Frame: Baseline and end line (12 weeks difference)
|
Family demographic data (family size, number of wives and children and ages) will be collected by questioning the mother.
|
Baseline and end line (12 weeks difference)
|
Photographs
Time Frame: through study completion, 12 weeks
|
Parents (and children, in the case of the school children) will be asked for permission to take photographs of them that illustrate the outcome measurements and supplement consumption, for the purpose of using in presentations on the research.
|
through study completion, 12 weeks
|
Change in weight
Time Frame: Baseline and end line (12 weeks difference)
|
Multiple measurements of weight to ±0.1 kg will be taken using a calibrated digital scale
|
Baseline and end line (12 weeks difference)
|
Change in height
Time Frame: Baseline and end line (12 weeks difference)
|
Duplicate measures of height will be made with an upright stadiometer measuring to 0.1 cm
|
Baseline and end line (12 weeks difference)
|
Change in circumferences
Time Frame: Baseline and end line (12 weeks difference)
|
Duplicate measurements of mid-upper arm circumference (MUAC) will be taken at the midpoint between the acromion process of scapula and olecranon process, and head circumference will be measured in duplicate at the widest diameter, using standardized World Health Organization (WHO) methods.
|
Baseline and end line (12 weeks difference)
|
Brain Hemoglobin
Time Frame: Endline at up to 12 weeks
|
Near infrared spectroscopy
|
Endline at up to 12 weeks
|
Brain Oxygenation
Time Frame: Endline at up to 12 weeks
|
Near infrared spectroscopy
|
Endline at up to 12 weeks
|
Brain Blood Flow
Time Frame: Endline at up to 12 weeks
|
Near infrared spectroscopy
|
Endline at up to 12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1200
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malnutrition
-
HAN University of Applied SciencesFrieslandCampina; HAS Hogeschool; Centre of Expertise Food (CoE Food); SligroCompletedMalnutrition; Protein | Protein MalnutritionNetherlands
-
International Centre for Diarrhoeal Disease Research...GlaxoSmithKline; Stanford UniversityCompletedMalnutrition | Malnutrition in Children | Child MalnutritionBangladesh
-
University of Nove de JulhoUnknownMalnutrition, ChildBrazil
-
International Centre for Diarrhoeal Disease Research...UNICEFNot yet recruitingMalnutrition SevereBangladesh
-
UNICEFSave the ChildrenCompletedSevere MalnutritionCongo, The Democratic Republic of the
-
University of Erlangen-Nürnberg Medical SchoolPfrimmer Nutricia GmbH, Erlangen , GermanyCompletedNursing Home Residents | Malnutrition or Risk of MalnutritionGermany
-
Aga Khan UniversityAction Contre la FaimCompletedEvaluation of the Effectiveness and Impact of Community Case Management of Severe Acute MalnutritionSevere MalnutritionPakistan
-
Action Against Hunger USAUniversity of Washington; Ethiopian Public Health InstituteNot yet recruitingModerate Acute Malnutrition | Severe Acute Malnutrition
-
Academy of Nutrition and DieteticsHartford Hospital; University of New Mexico; Meals on Wheels Central TexasNot yet recruiting
-
Diego MorettiSwiss Federal Institute of Technology; Wageningen University and Research; St... and other collaboratorsCompletedMalnutrition; ProteinSwitzerland
Clinical Trials on Supplement
-
Texas Tech UniversityEHP LabsCompletedBody Weight Changes | Body Composition Changes | Anthropometric Changes | Metabolism Changes | Hemodynamic ChangesUnited States
-
Universidade Federal do AmazonasCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Hospital Universitario... and other collaboratorsCompletedOverweight | HypercholesterolemiaBrazil
-
Chair for Biomarkers of Chronic DiseasesKing AbdulAziz City for Science and TechnologyRecruitingObesity | Metabolic DiseaseSaudi Arabia
-
Griffin HospitalISOThrive Inc.Completed
-
Wageningen UniversityCompletedInflammation | Glucose Tolerance | Lipid Homeostasis | Vascular FunctionNetherlands
-
Probi ABCompleted
-
Maastricht University Medical CenterNutricia ResearchRecruitingPulmonary Disease, Chronic ObstructiveNetherlands
-
Hospital Universitari Vall d'Hebron Research InstituteNot yet recruiting
-
Wageningen University and ResearchNexira; Roquette Freres; Bioiberica; Ingredion Incorporated; Naturex; Ministery of... and other collaboratorsCompleted